Harnessing Biomedical Innovation: Modernizing VA Healthcare for the Future

VA Budget and ModernizationHouse Veterans' Affairs · April 1, 2025 · 119th Congress
The House Veterans' Affairs Committee held this hearing to examine how the VA acquires and deploys new medical technologies — such as diabetic foot ulcer monitoring, cardiac devices, imaging, and sleep apnea tools — and what barriers slow adoption. Begins at ▶ 0:09:49
Transcript
Highlights

Title

VA medical technology procurement amid workforce cuts

Purpose

The House Veterans' Affairs Committee held this hearing to examine how the VA acquires and deploys new medical technologies — such as diabetic foot ulcer monitoring, cardiac devices, imaging, and sleep apnea tools — and what barriers slow adoption. Democrats used the hearing to criticize the VA's absence from the witness table and to warn that planned workforce reductions of up to 80,000-83,000 employees could undermine the ability to operate any new equipment purchased. Begins at▶ 0:09:49

Who spoke

• Chairman Mike Bost (R-IL)▶ 0:09:49: Opened by framing the hearing around cutting red tape in VA technology acquisition, citing that one in four VA patients has diabetes and heart disease is the top cause of hospitalization▶ 0:12:07; later pushed back on Democrats' staffing-cut framing, saying no final reduction number exists and calling a leaked memo "not a plan"▶ 2:24:57.

• Ranking Member Mark Takano (D-CA)▶ 0:14:02: Argued VA cuts force facilities to choose between staff and equipment▶ 0:15:24, displayed posters of a closed Greenville, NC prosthetics window and a cancelled Danville mobile MRA contract▶ 0:15:53▶ 0:16:21, and noted VA declined the minority's invitation to testify▶ 0:18:00; in closing, disputed Dr. Murphy's account of the Greenville clinic using VA's own documents▶ 2:15:05 and cited Secretary Collins confirming an 80,000-job cut on Fox and Friends▶ 2:19:30.

• Will Gray, Boston Scientific▶ 0:24:20: Testified 61% of U.S. AFib ablations will use Boston Scientific's pulse field ablation (Ferrapulse) this year, but fewer than 10% of VA hospitals have it▶ 0:28:14; said the MSPV contract works well but the PASS prosthetics contract lacks a process to add new products▶ 0:27:50; declined to provide requested pricing data, calling it proprietary▶ 0:53:04.

• Dr. Jon Bloom, Podimetrics▶ 0:29:41: Said 85% of lower-limb amputations stem from diabetic foot ulcers with a 70% five-year mortality rate▶ 0:30:41; described the VA's remote temperature-monitoring "smart mat" program cutting one-year mortality by 37% and saving roughly $16,000 per veteran per year▶ 0:32:07▶ 0:32:35; said scaling to all 110,000 high-risk veterans could save $1.8 billion annually▶ 0:32:51.

• Jeff DiLullo, Philips North America▶ 0:34:52: Described Philips' TeleCritical Care and proposed Radiology Operations Command Center ("ROCK") to network VA's 25 million annual imaging scans▶ 0:38:16; detailed the DoD-partnered "RATE" wearable biomarker program piloted on 11,000 service members▶ 1:18:07; agreed to provide contract pricing information when pressed by Takano▶ 0:53:33.

• Dr. Sai Parthasarathy, University of Arizona▶ 0:40:31: Said research-to-practice adoption typically takes 17 years▶ 0:42:19; described AI algorithms embedded in electronic health records to flag undiagnosed sleep apnea, noting one in four cases go undiagnosed▶ 0:43:52▶ 0:44:14; discussed a virtual-imagery PTSD diagnostic tool tested on war-theater veterans▶ 1:22:19.

• Rep. Greg Murphy (R-NC)▶ 0:56:11: Disputed Takano's characterization of the Greenville facility, stating the prosthetics department remains open Monday–Friday 8am-4:30pm and only a service window was closed▶ 0:57:08; pressed all witnesses on cost containment▶ 0:58:03.

• Rep. Julia Brownley (D-CA)▶ 1:01:15: Asked Gray how hiring freezes and workforce cuts affect stability of VA-industry partnerships▶ 1:03:49.

• Rep. Mike Barrett (?)▶ 1:06:38: Asked Bloom about GLP-1 drugs as a preventative for diabetes▶ 1:07:07 and DiLullo about reducing duplicative testing through EHR interoperability▶ 1:09:15.

• Rep. Morgan Luttrell (?)/Rep. Sheffley McCormack▶ 1:11:22: Argued VA lacks the structure and personnel to ensure new technologies succeed, pressing witnesses on whether VA has adequate resources for prevention▶ 1:12:36▶ 1:15:41.

• Rep. Juan Ciscomani (R-AZ)▶ 1:16:38: Asked DiLullo about the "RATE" (Rapid Analysis of Threat Exposure) wearable program and its potential VHA expansion▶ 1:17:38; also questioned Parthasarathy on AI-enhanced patient care at the University of Arizona▶ 1:20:12.

• Rep. Delia Ramirez (D-IL)▶ 1:23:03: Accused the majority of using the hearing to advance privatization, comparing it to a "Musk bad boss playbook"▶ 1:45:00; pressed DiLullo on whether Philips could operate with 15% workforce cuts▶ 1:45:53.

• Rep. Morgan McGarvey (D-KY)▶ 1:33:36: Proposed a VA "DARPA" model, referenced his Innovate Act providing other transaction authority and advanced market commitments▶ 1:37:13, noting the model produced the Malaria vaccine saving 700,000 lives▶ 1:37:43.

• Rep. Mariannette Miller-Meeks (R-IA)▶ 1:38:36: Asked witnesses whether technology displaces jobs▶ 1:39:07 and questioned Bloom on diabetic foot ulcer consequences and Bloom's engagement with VA's Office of Health Innovation▶ 1:40:26▶ 1:41:23.

• Rep. Delia Ramirez / Rep. (unclear, "Representative Dexter") — see above.

• Rep. (unclear, "General Burkeman")▶ 1:49:55: A veteran member who pressed Gray on why only 10% of VA hospitals have pulse field ablation despite 61% civilian adoption▶ 1:50:47, and compared VA and DoD procurement (ECAT vs. MSPV)▶ 1:53:32.

• Rep. Maxine Dexter (D-OR)▶ 1:54:52: A pulmonary/critical-care physician who criticized the hearing format, noting Boston Scientific's cited Ferrapulse study was funded by Boston Scientific itself and was a non-inferiority trial▶ 1:57:00▶ 1:57:28.

• Rep. Yassamin Ansari/Rep. Sisammani (D-AZ)▶ 2:00:02: Asked Bloom why only 63 of 1,727 eligible diabetic veterans in her district use the monitoring program despite $16,000 per-patient savings▶ 2:01:22; asked DiLullo about lung disease diagnostics for veterans▶ 2:03:20.

• Rep. (unclear speaker, "Dr.")▶ 2:05:19: Raised concerns about deferred maintenance and pressed Gray on inefficiencies in the prosthetics procurement contract▶ 2:09:17.

• Rep. Timothy Kennedy (D-NY)▶ 2:11:03: Cited the VA's cancellation of 900 contracts affecting cancer care and prosthetics, and described understaffed nurses picketing at the Buffalo VA▶ 2:12:33▶ 2:14:13.

Key moments

• Gray testified pulse field ablation will account for 61% of U.S. AFib procedures this year, yet fewer than 10% of VA hospitals have access to the technology, attributing the gap to budget uncertainty and the PASS contract's lack of a product-addition window▶ 0:28:14▶ 1:51:17.

• Bloom said VA's remote foot-monitoring program detects 97% of diabetic foot ulcers five weeks before clinicians otherwise would, cut one-year mortality 37%, and saved an estimated $100 million with fewer than 6% of eligible veterans enrolled — projecting $1.8 billion in annual savings and 5,000 lives saved if scaled to all 110,000 high-risk veterans▶ 0:32:07▶ 0:32:51.

• Takano asked Gray and DiLullo to provide full pricing data within a week; Gray called the information proprietary while DiLullo agreed to share contract pricing▶ 0:52:05▶ 0:53:04▶ 0:53:33.

• A dispute over the Greenville, NC facility: Takano displayed a photo dated March 21 showing the prosthetics service window closed; Murphy said the department remains open Monday-Friday; Takano later showed the VA's own document (dated March 18) stating the window "will remain closed until further notice," and Bost said the VA later confirmed only the window, not the clinic, was closed▶ 0:15:53▶ 0:57:08▶ 2:15:05▶ 2:22:13.

• Dexter noted the only evidence Boston Scientific cited for Ferrapulse's value was a company-funded, non-inferiority trial, arguing the hearing bypassed VA's actual procurement review process▶ 1:57:00▶ 1:57:28.

• Bloom described a patient who stopped using the monitoring mat and, when contacted, revealed suicidal ideation over limb pain before being connected to services▶ 1:40:56.

• DiLullo detailed the DoD-developed "RATE" wearable program, piloted with 11,000 service members, that predicts infection onset up to 48 hours before symptoms appear▶ 1:18:29▶ 1:19:45.

• Ramirez asked whether Philips could operate effectively with a 15% workforce cut (~2,550 employees); DiLullo said it would be "harder" but treated it as an opportunity to automate▶ 1:45:53▶ 1:46:11.

• Takano said VA has answered only 3 of 22 letters from committee Democrats and that Secretary Collins has not met with any Democratic committee member in two months▶ 2:18:37.

• Miller-Meeks noted VA added 80,000 employees over the last four years alongside a $126 billion budget increase while care levels stayed flat, framing coming reductions as a normal correction▶ 1:39:31.

Metadata

CommitteeHouse Veterans' Affairs
Chamber / CongressHouse · 119th Congress
DateApril 1, 2025
TypeHearing
Witnesses
Mr. Jeff DiLullo — Executive Vice President and Chief Regional Leader, Philips North America
Mr. Will Gray — Vice President, Marketing, Commercial Operations, and Government, Boston Scientific
Dr. Jon Bloom — Chief Executive Officer, Podimetrics
Dr. Sai Parthasarathy — Director, Center for Sleep, Circadian and Neuroscience Research, University of Arizona Health Sciences
Videoyoutube
Transcript313 caption blocks · 23,344 words · 2:27:25 runtime
EventCongress.gov 118042